rs121918731
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000359.3(TGM1):c.919C>T(p.Arg307Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R307G) has been classified as Pathogenic.
Frequency
Consequence
NM_000359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGM1 | NM_000359.3 | c.919C>T | p.Arg307Trp | missense_variant | 6/15 | ENST00000206765.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.919C>T | p.Arg307Trp | missense_variant | 6/15 | 1 | NM_000359.3 | P1 | |
TGM1 | ENST00000559136.1 | c.-9C>T | 5_prime_UTR_variant | 2/7 | 5 | ||||
TGM1 | ENST00000544573.5 | c.-28-1381C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000132 AC: 2AN: 152026Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248966Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135004
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1460950Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726762
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:6
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2001 | - - |
Pathogenic, criteria provided, single submitter | in vitro | Medical Genetics Laboratory, West China Hospital, Sichuan University | Jan 17, 2020 | The newborn's entire body was covered with a thin transparent collodion membrane. Variant c.919 C>T was evaluated to be deleterious by PolyPhen-2, PROVEAN and Mutation Taster and amino acid was highly conserved in multiple species. Additionally, in vitro functional studies indicated that TGM1 protein expression levels significantly decreased in cells with c.919 C>T mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 30, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Feb 26, 2018 | - - |
Lamellar ichthyosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 23, 2022 | Variant summary: TGM1 c.919C>T (p.Arg307Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 248966 control chromosomes (gnomAD). c.919C>T has been reported in the literature as a biallelic genotype in multiple individuals affected with Lamellar Ichthyosis, predominantly from individuals of East Asian descent (e.g. Akiyama_2001, Muramatsu_2004, Sakai_2009, Yamamoto_2012, Yang_2001). These data indicate that the variant is very likely to be associated with disease. When TGase 1 activity was assayed in cultured keratocytes from a compound heterozygous proband and their unaffected carrier parent, there was 5% activity in the proband and 50% activity in the carrier parent, suggesting the variant may have limited functionality (Yang_2001). Four ClinVar submitters have assessed the variant since 2014: one classified the variant as likely pathogenic and three as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 08, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg307 amino acid residue in TGM1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16968736, 19863506, 26076875, 27025581, 28403434). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TGM1 protein function. ClinVar contains an entry for this variant (Variation ID: 12499). This missense change has been observed in individuals with lamellar ichthyosis and self-improving collodion ichthyosis (PMID: 11407995, 11511296, 19262603, 20167857, 21895619, 24419105). This variant is present in population databases (rs121918731, gnomAD 0.02%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 307 of the TGM1 protein (p.Arg307Trp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at